BACKGROUND: Survival from breast cancer (BC) in Estonia has been consistently among the lowest in Europe. The aim of this study was to examine most recent trends in BC survival in Estonia by age and stage. The trends in overall BC incidence and mortality are also shown in the paper. MATERIAL AND METHODS: Estonian Cancer Registry data on all cases of BC, diagnosed in women in Estonia during 1995-2007 (n = 7424) and followed up for vital status through 2009, were used to estimate relative survival ratios (RSR). Period hybrid approach was used to obtain the most recent estimates (2005-2009). Stage was classified as localized, local/regional spread or distant. RESULTS: BC incidence continued to rise throughout the study period, but mortality has been in steady decline since 2000. The distribution of patients shifted towards older age and earlier stage at diagnosis. Overall age-standardized five-year RSR increased from 63% in 1995-1999 to 74% in 2005-2009. Younger age groups experienced a more rapid improvement compared to women over 60. Significant survival increase was observed for both localized and locally/regionally spread BC with five-year RSRs reaching 96% and 70% in 2005-2009, respectively; the latest five-year RSR for distant BC was 11%. Survival for T4 tumors was poor and large age difference was seen for locally/regionally spread BC. CONCLUSIONS: Considerable improvement in BC survival was observed over the study period. Women under 60 benefited most from both earlier diagnosis and treatment advances of locally/regionally spread cancers. However, the survival gap with more developed countries persists. Further increase in survival, but also decline in BC mortality in Estonia could be achieved by facilitating early diagnosis in all age groups, but particularly among women over 60. Investigations should continue to clarify the underlying mechanisms of the stage-specific survival deficit in Estonia.
BACKGROUND: Survival from breast cancer (BC) in Estonia has been consistently among the lowest in Europe. The aim of this study was to examine most recent trends in BC survival in Estonia by age and stage. The trends in overall BC incidence and mortality are also shown in the paper. MATERIAL AND METHODS: Estonian Cancer Registry data on all cases of BC, diagnosed in women in Estonia during 1995-2007 (n = 7424) and followed up for vital status through 2009, were used to estimate relative survival ratios (RSR). Period hybrid approach was used to obtain the most recent estimates (2005-2009). Stage was classified as localized, local/regional spread or distant. RESULTS: BC incidence continued to rise throughout the study period, but mortality has been in steady decline since 2000. The distribution of patients shifted towards older age and earlier stage at diagnosis. Overall age-standardized five-year RSR increased from 63% in 1995-1999 to 74% in 2005-2009. Younger age groups experienced a more rapid improvement compared to women over 60. Significant survival increase was observed for both localized and locally/regionally spread BC with five-year RSRs reaching 96% and 70% in 2005-2009, respectively; the latest five-year RSR for distant BC was 11%. Survival for T4 tumors was poor and large age difference was seen for locally/regionally spread BC. CONCLUSIONS: Considerable improvement in BC survival was observed over the study period. Women under 60 benefited most from both earlier diagnosis and treatment advances of locally/regionally spread cancers. However, the survival gap with more developed countries persists. Further increase in survival, but also decline in BC mortality in Estonia could be achieved by facilitating early diagnosis in all age groups, but particularly among women over 60. Investigations should continue to clarify the underlying mechanisms of the stage-specific survival deficit in Estonia.
Authors: Andreu Nolasco; Joaquin Moncho; Jose Antonio Quesada; Inmaculada Melchor; Pamela Pereyra-Zamora; Nayara Tamayo-Fonseca; Miguel Angel Martínez-Beneito; Oscar Zurriaga; Mónica Ballesta; Antonio Daponte; Ana Gandarillas; M Felicitas Domínguez-Berjón; Marc Marí-Dell'Olmo; Mercè Gotsens; Natividad Izco; M Concepción Moreno; Marc Sáez; Carmen Martos; Pablo Sánchez-Villegas; Carme Borrell Journal: Int J Equity Health Date: 2015-04-01
Authors: Kaire Innos; Peeter Padrik; Vahur Valvere; Evelyn Eelma; Riina Kütner; Jaak Lehtsaar; Mare Tekkel Journal: BMC Public Health Date: 2013-10-09 Impact factor: 3.295
Authors: Andreu Nolasco; Pamela Pereyra-Zamora; Elvira Sanchis-Matea; Nayara Tamayo-Fonseca; Pablo Caballero; Inmaculada Melchor; Joaquín Moncho Journal: Int J Environ Res Public Health Date: 2018-10-19 Impact factor: 3.390